We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bronsther to Participate in Panel on Raising Funds in Biotech Oscar L. Bronsther, M.D., CEO of MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and...
Interviews Spotlight Importance of Company’s Diagnostic Tests for Predicting Metastasis in Patients with Breast Cancer MetaStat, Inc. (OTCQB: MTST), a molecular diagnostic company focused...
Thirty Years of Biopharmaceutical Industry Experience Includes Leadership, Development and Commercialization MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on...
-- Company Raises Total Gross Proceeds of $3.4 Million -- MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic...
Research Represents Next Step Forward in Path Toward Commercialization of Company’s Diagnostic Tests MetaStat, Inc. (OTCQB: MTST), a molecular diagnostic company focused on developing and...
MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing epigenetic-based diagnostic tests for early and reliable prediction of systemic...
CEO Oscar L. Bronsther to Present on Tuesday, January 13 at 10:30 AM PT MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on developing and commercializing...
Becomes Pure-Play Molecular Diagnostics Company, Focused Exclusively on Developing and Commercializing Epigenetic-based Diagnostic Tests to Determine the Risk of Developing Systemic...
Company’s Diagnostic Tests for Early Detection of Systemic Metastasis Spotlighted in Boston Magazine, Medical Device Daily and MedCity News MetaStat, Inc. (OTCQB:MTST), a molecular...
Decades of Experience Add Strength to Board MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on understanding and treating systemic metastasis, appointed Richard J...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.0005 | 0.0005 | 0.0005 | 0 | 0 | CS |
4 | 0 | 0 | 0.0005 | 0.0005 | 0.0002 | 24250 | 0.00021546 | CS |
12 | 0.0004 | 400 | 0.0001 | 0.0005 | 0.0001 | 19400 | 0.00021546 | CS |
26 | 0.0004 | 400 | 0.0001 | 0.0005 | 0.0001 | 12125 | 0.00021546 | CS |
52 | 0.0004 | 400 | 0.0001 | 0.0005 | 0.0001 | 12125 | 0.00021546 | CS |
156 | -0.0025 | -83.3333333333 | 0.003 | 0.003 | 1.0E-6 | 13690 | 8.839E-5 | CS |
260 | -0.0395 | -98.75 | 0.04 | 0.075 | 1.0E-6 | 18152 | 0.00894487 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions